Novo Nordisk or Pfizer: Which Healthcare Giant Is the Better Bet?Zacks Investment Research • 11/27/25
Novo Nordisk Seeks Extra-Fast Nod From FDA for Higher Dose of WegovyZacks Investment Research • 11/27/25
Why Medicare price negotiations matter for Novo Nordisk, AstraZeneca, and other European pharma companiesCNBC • 11/26/25
NVO Stock Up as Amycretin Shows Strong Weight Loss in Type 2 DiabetesZacks Investment Research • 11/26/25
Medicare Slashes Ozempic's Price Tag 71%; Why Novo Nordisk RalliedInvestors Business Daily • 11/26/25
Undeterred by Novo Nordisk failure, scientists consider GLP-1s as Alzheimer's preventionReuters • 11/25/25
Novo Nordisk Signals 2026 Push After Amycretin Posts Major Phase 2 Gains In Type 2 Diabetes PatientsBenzinga • 11/25/25
Novo Nordisk Stock Jumps on Positive Weight-Loss Drug Data. Why It Deserves Better.Barrons • 11/25/25
Novo Nordisk's Longshot Alzheimer's Trial Didn't Work, But It Is Still Worth BuyingSeeking Alpha • 11/25/25